Merial Sponsors HITS for 2016 and 2017 Show Seasons

Avatar:
Author:
Publish date:
Social count:
0

Merial and HITS are thrilled to announce their corporate partnership for the 2016 and 2017 show seasons. As part of the multi-year sponsorship, Merial brands ULCERGARD (omeprazole), LEGEND (hyaluronate sodium) and EQUIOXX (firocoxib) will be featured.

ULCERGARD, the only product proven and FDA-approved to prevent stomach ulcers in horses,1 has been designated the title sponsor for the $100,000 ULCERGARD Grand Prix at HITS Saugerties. LEGEND, proven to safely and effectively fight non-infectious synovitis associated with equine osteoarthritis,2 will be the title sponsor for the LEGEND VIP Club at HITS Saugerties. And finally, EQUIOXX, providing 24 hours of pain relief* in just one daily dose,3 is the title sponsor for the $50,000 EQUIOXX Grand Prix at HITS Ocala.

“We would like to thank Merial for their support of the HITS shows,” said Chris Mayone, HITS Sponsorship Director. “Merial is respected for the quality products they provide, and it’s an honor to have Merial on board as a sponsor for the next two years.”

“Merial has a long-standing commitment to being a leader in performance horse health,” said Beckie Peskin, Associate Director of Equine Marketing for Merial. “Our products help horses be prepared for competition, and sponsoring the HITS shows is part of our dedication to support organizations and people who comprise the foundation of the equine industry.”

Merial began sponsoring HITS in 2015. The new sponsorship will continue at least until the end of 2017.

*Joint pain and inflammation associated with equine osteoarthritis, also called degenerative joint disease.

Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health and well-being of a wide range of animals. Merial employs 6,100 people and operates in more than 150 countries worldwide with over €2 billion of sales in 2014. Merial is a Sanofi company. For more information, please see www.merial.com.

HITS, Inc. produces high-quality, international-level hunter/jumper horse shows. Based in upstate New York in the Village of Saugerties, HITS has been producing shows since 1982 and is now a nationwide company with world-class circuits in California, Florida, Arizona, New York and Virginia. For more information and a complete schedule of classes and events, visit www.HitsShows.com. Stay connected with HITS! Join us on Facebook and follow us on Twitter and Instagram. Media should contact the HITS Media Team at 845-246-8833 or email media_info@HitsShows.com.

IMPORTANT SAFETY INFORMATION:
ULCERGARD can be used in horses that weigh at least 600 pounds. Safety in pregnant mares has not been determined.

IMPORTANT SAFETY INFORMATION: The safety of LEGEND has not been evaluated in breeding stallions or in breeding, pregnant or lactating mares. The following adverse reactions have been reported following use of LEGEND Injectable Solution: Following intravenous use: occasional depression, lethargy, and fever. Following intra-articular (LEGEND Injectable Solution – 2 mL only) use: lameness, joint effusion, joint or injection site swelling, and joint pain.

IMPORTANT SAFETY INFORMATION
As with any prescription medication, prior to use, a veterinarian should perform a physical examination and review the horse’s medical history. A veterinarian should advise horse owners to observe for signs of potential drug toxicity. As a class, nonsteroidal anti‐inflammatory drugs may be associated with gastrointestinal, hepatic and renal toxicity. Use with other NSAIDs, corticosteroids or nephrotoxic medication should be avoided. EQUIOXX has not been tested in horses less than 1 year of age or in breeding horses, or pregnant or lactating mares. For additional information, please refer to the prescribing information or visit www.equioxx.com.

ULCERGARD, LEGEND and EQUIOXX are registered trademarks of Merial. ©2016 Merial, Inc., Duluth, GA. All rights reserved. EQUILGN1618 (01/16)